These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The frequency in New Zealand of a mitochondrial DNA mutation (1555 A to G) associated with aminoglycoside-induced hearing loss. Scrimshaw BJ, Faed JM, Tate WP, Yun K. N Z Med J; 1999 Jun 11; 112(1089):216-7. PubMed ID: 10414625 [No Abstract] [Full Text] [Related]
29. Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells. So HS, Park C, Kim HJ, Lee JH, Park SY, Lee JH, Lee ZW, Kim HM, Kalinec F, Lim DJ, Park R. Hear Res; 2005 Jun 11; 204(1-2):127-39. PubMed ID: 15925198 [Abstract] [Full Text] [Related]
31. [Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects]. Liao YJ, Tang H. Sheng Li Ke Xue Jin Zhan; 2003 Jul 11; 34(3):266-9. PubMed ID: 14628479 [No Abstract] [Full Text] [Related]
33. [Ultrasonic lateralization test in the diagnosis of early forms of sensorineural hearing loss]. Kolesova LI. Vestn Otorinolaringol; 1983 Jul 11; (3):20-3. PubMed ID: 6868264 [No Abstract] [Full Text] [Related]
37. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters. Lanvers-Kaminsky C, Krefeld B, Dinnesen AG, Deuster D, Seifert E, Würthwein G, Jaehde U, Pieck AC, Boos J. Pediatr Blood Cancer; 2006 Aug 11; 47(2):183-93. PubMed ID: 16302218 [Abstract] [Full Text] [Related]
39. Audiologic testing and molecular analysis of 12S rRNA in patients receiving aminoglycosides. Gürtler N, Schmuziger N, Kim Y, Mhatre AN, Jungi M, Lalwani AK. Laryngoscope; 2005 Apr 11; 115(4):640-4. PubMed ID: 15805873 [Abstract] [Full Text] [Related]